BioAtla, Inc. (BCAB) Tops Q1 EPS by 6c

BioAtla, Inc. (NASDAQ: BCAB) reported Q1 EPS of ($0.48), $0.06 better than the analyst estimate of ($0.54).

For earnings history and earnings-related data on BioAtla, Inc. (BCAB) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Blue Owl keeps 5% redemption caps as OCIC requests ease from prior quarter
• Lucid reports Q2 output, names new CFO and five other leaders